BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 222892)

  • 1. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1979 Aug; 210(2):174-9. PubMed ID: 222892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence.
    Vaught JL; Takemori AE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):86-90. PubMed ID: 569699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to morphine bradycardia in the rat.
    Kiang JG; Dewey WL; Wei ET
    J Pharmacol Exp Ther; 1983 Jul; 226(1):187-91. PubMed ID: 6864538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid mechanisms of some behavioral effects of ketamine.
    Fidecka S
    Pol J Pharmacol Pharm; 1987; 39(4):353-60. PubMed ID: 3449808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intraventricular morphine and enkephalins on locomotor activity in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Sep; 218(3):613-20. PubMed ID: 7021799
    [No Abstract]   [Full Text] [Related]  

  • 12. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-ala2-methionine-enkephalinamide self-administration in the morphine-dependent rat.
    Tortella FC; Moreton JE
    Psychopharmacology (Berl); 1980; 69(2):143-7. PubMed ID: 6779307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
    Miglécz E; Székely JI; Dunai-Kovács Z
    Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Met-enkephalin on body temperature of normal and morphine-tolerant rats.
    Ferri S; Arrigo Reina R; Santagostino A; Scoto GM; Spadaro C
    Psychopharmacology (Berl); 1978 Jul; 58(3):277-81. PubMed ID: 98798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of morphine tolerance and withdrawal on intestinal salt and water transport in the rat in vivo and in vitro.
    Warhurst G; Smith GS; Higgs N; Tonge A; Turnberg LA
    Gastroenterology; 1984 Nov; 87(5):1035-41. PubMed ID: 6541171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epileptic properties of leucine- and methionine-enkephalin: comparison with morphine and reversibility by naloxone.
    Frenk H; Urca G; Liebeskind JC
    Brain Res; 1978 May; 147(2):327-37. PubMed ID: 206315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.